Cephalon acquiring cancer company Gemin X for $225 million in cash, plus up to $300 million in milestones

Gemin X Pharmaceuticals Inc.

U.S. / Private Biopharma

Seller

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Cephalon Inc.

U.S. / Mid-Cap Biopharma ($1-$50 billion)

$4,234.8m on 03/18/2011 [market cap]

Buyer

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Completed

Sample

01/01/2009

announced

01/01/2009

completed